Determinants of fluconazole resistance and echinocandin tolerance in <i>C. parapsilosis</i> isolates causing a large clonal candidemia outbreak among COVID-19 patients in a Brazilian ICU

Farnaz Daneshnia(Massachusetts General Hospital), Arnaldo Lopes Colombo(Universidade Federal de São Paulo), João Nóbrega de Almeida(Universidade Federal de São Paulo), Geraldine Butler(University College Dublin), Lisa Lombardi(University College Dublin), Lis Moreno(D’Or Institute for Research and Education), Amir Arastehfar(Harvard University), Erika Shor(Georgetown University), David S. Perlin(Georgetown University), Ana Verena Almeida Mendes(Escola Bahiana de Medicina e Saúde Pública), Maria Goreth Barberino(Hospital São Rafael)
Figshare
January 1, 2022
10.6084/m9.figshare.20983588
Cited by 0

Related Papers

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
|The Lancet|2020|5k
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium
|The Lancet Infectious Diseases|2019|1.7k
Simultaneous Emergence of Multidrug-Resistant <i>Candida auris</i> on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses
|Clinical Infectious Diseases|2016|1.6k
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
|The Lancet|2021|1.2k
Mechanisms of Antifungal Drug Resistance
|Cold Spring Harbor Perspectives in Medicine|2014|613